Skip to content

GRAIL, Inc. GRAL Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Immunome logo
ImmunomeIMNM
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
Erasca, Inc. logo
Erasca, Inc.ERAS

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s software and technology licenses, net?
GRAIL, Inc. (GRAL) reported software and technology licenses, net of $7.27M in Q1 2026.
How has GRAIL, Inc.'s software and technology licenses, net changed year-over-year?
GRAIL, Inc.'s software and technology licenses, net decreased by 1.1% year-over-year, from $7.35M to $7.27M.
What is the long-term trend for GRAIL, Inc.'s software and technology licenses, net?
Over 2 years (2023 to 2025), GRAIL, Inc.'s software and technology licenses, net has grown at a -8.0% compound annual growth rate (CAGR), from $7.98M to $6.75M.